Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does NAPROXEN Cause Maternal exposure during pregnancy? 1,550 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 1,550 reports of Maternal exposure during pregnancy have been filed in association with NAPROXEN (Naproxen Sodium). This represents 2.9% of all adverse event reports for NAPROXEN.

1,550
Reports of Maternal exposure during pregnancy with NAPROXEN
2.9%
of all NAPROXEN reports
1,026
Deaths
1,060
Hospitalizations

How Dangerous Is Maternal exposure during pregnancy From NAPROXEN?

Of the 1,550 reports, 1,026 (66.2%) resulted in death, 1,060 (68.4%) required hospitalization, and 1,109 (71.5%) were considered life-threatening.

Is Maternal exposure during pregnancy Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for NAPROXEN. However, 1,550 reports have been filed with the FAERS database.

What Other Side Effects Does NAPROXEN Cause?

Drug ineffective (12,416) Product use issue (4,865) Off label use (4,434) Drug hypersensitivity (4,160) Pain (4,140) Nausea (4,139) Vomiting (3,889) Fatigue (3,659) Diarrhoea (3,498) Dizziness (3,460)

What Other Drugs Cause Maternal exposure during pregnancy?

CERTOLIZUMAB PEGOL (9,013) ADALIMUMAB (7,518) PREDNISONE (6,587) METHOTREXATE (6,223) RITUXIMAB (6,093) INFLIXIMAB (6,061) HYDROXYCHLOROQUINE (5,809) FOLIC ACID (5,768) TOCILIZUMAB (5,737) LEFLUNOMIDE (5,643)

Which NAPROXEN Alternatives Have Lower Maternal exposure during pregnancy Risk?

NAPROXEN vs NAPROXEN\NAPROXEN NAPROXEN vs NAPROXEN\PSEUDOEPHEDRINE NAPROXEN vs NAPROXEN\SUMATRIPTAN NAPROXEN vs NARATRIPTAN NAPROXEN vs NASONEX

Related Pages

NAPROXEN Full Profile All Maternal exposure during pregnancy Reports All Drugs Causing Maternal exposure during pregnancy NAPROXEN Demographics